Tata Consumer Rights Issue: Company announces ₹3,000 cr rights issue: Key dates

Tata Consumer, tata consumer share, tata consumer share price, tata consumer products, tata power share price, tata power share, tata consumer share price today, tata consumer rights issue, tata motors share, tata motors share price, tata consumer share price nse. tata consumer products share, tata consumer products share price, tata consumer products rights issue, tata consumer rights issue, tata consumer products news, tata consumer results, tata consumer news, tata consumer share price target 2025,

Tata Consumer Rights Issue: Tata Consumer, a part of salt to aviation conglomerate Tata Group, announced a rights issue worth ₹3,000 crore on Tuesday. The rights will be issued at ₹818 per share.

Indus Design School announces Aikyam: Premier student-led design fest

Indus Design School has announced Aikyam, a premier design fest led by students, celebrating creativity, connections, inspirations, and core values. Taking place from July 18th to 20th, 2024, Aikyam will feature insights from esteemed industry professionals, interactive exhibits, and engaging workshops. This festival is dedicated to nurturing a positive design culture, promoting ethical and impactful … Read more

Infosys foundation to enhance employability of young learners in rural India with ICT Academy

Infosys Foundation, the philanthropic and CSR arm of Infosys, has signed a Memorandum of Understanding (MoU) with ICT Academy of Tamil Nadu, a non-profit organization, to increase the employability of young learners in rural India. This collaboration will aim to enable students pursuing engineering, arts, and science courses in tier 2 and tier 3 cities … Read more

Biocon Biologics’ obtains US FDA approval for biosimilar aflibercept for Yesafili

Biocon

Global biosimilars company and subsidiary of Biocon Ltd Biocon Biologics Ltd on Tuesday announced that the US Food and Drug Administration (US FDA) has approved the company’s first-to-file application for Yesafili™ (aflibercept-jbvf), an interchangeable biosimilar aflibercept. YESAFILI, a vascular endothelial growth factor (VEGF) inhibitor used to treat several different types of ophthalmology conditions, is a … Read more

Coforge launches Copilot Innovation Hub with Microsoft to accelerate enterprise adoption of Generative AI

coforge

Digital services and solutions provider Coforge has collaborated with Microsoft to establish the Coforge Copilot Innovation Hub. The Hub will focus on developing a pipeline of new industry specific generative AI solutions and will work closely with Microsoft to integrate these solutions with Microsoft’s generative AI products and technologies, including Microsoft Azure OpenAI Service, Microsoft Power Platform, and Microsoft Copilot.